Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to Therapy.

Sears, Connie M; Azad, Amee D; Dosiou, Chrysoula; Kossler, Andrea L

Sears, Connie M; Azad, Amee D; Dosiou, Chrysoula; Kossler, Andrea L.

Affiliation

Sears CM; Department of Ophthalmology, Byers Eye Institute.
Azad AD; Department of Ophthalmology, Byers Eye Institute.
Dosiou C; Department of Medicine-Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Palo Alto, California, U.S.A.
Kossler AL; Department of Ophthalmology, Byers Eye Institute.

Ophthalmic Plast Reconstr Surg ; 37(3S): S157-S160, 2021.

Article in En | MEDLINE | ID: mdl-32976335

Subject(s)

Graves Ophthalmopathy; Optic Nerve Diseases; Antibodies, Monoclonal, Humanized; Graves Ophthalmopathy/diagnosis; Graves Ophthalmopathy/drug therapy; Humans; Male; Middle Aged; Optic Nerve; Optic Nerve Diseases/diagnosis; Optic Nerve Diseases/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Optic Nerve Diseases / Graves Ophthalmopathy Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google